Skip to content

Exploration of the Efficacy of Neuromodulation and Electrical Stimulation in Treating Amyotrophic Lateral Sclerosis

Exploration of the Efficacy of Neuromodulation and Electrical Stimulation in Treating Amyotrophic Lateral Sclerosis - Exploration of the Efficacy of Neuromodulation and Electrical Stimulation in Treating ALS

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112025
Enrollment
Unknown
Registered
2025-11-10
Start date
2025-11-10
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amyotrophic lateral sclerosis

Interventions

Test group:Suregery, Motor Cortical Electrical Stimulation

Sponsors

Peking University International Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with ALS 2. Age from 18 to 85 years old; 3. FVC >= 60% expected value; 4. Outpatient completed electromyography and single photon emission computed tomography examinations; 5. Voluntarily joining this study, signing an informed consent form, demonstrating good compliance, and willing to cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1. Diseases related to surgical contraindications, including but not limited to: severe infection or inflammation, coagulation dysfunction, severe cardiovascular disease; 2. Laboratory tests (blood routine, coagulation function, liver and kidney function, etc.) are abnormal, and the researcher has determined that surgery is not suitable; 3. Imaging examinations such as magnetic resonance imaging (MRI) or computed tomography (CT) cannot determine the anatomical location of the motor cortex based on the researcher's judgment; 4. Metal implants within a stimulation range of 30cm; 5. After implantation of cardiac pacemaker; 6. History of refractory epilepsy in the past, currently epilepsy has not been controlled; 7. Pregnant or lactating women; 8. Previously received deep brain stimulation; 9. Other circumstances deemed unsuitable by the investigator to participate in this study.

Design outcomes

Primary

MeasureTime frame
Changes in ALS functional scale and baseline after surgery in patients;

Secondary

MeasureTime frame
Changes in the Postoperative Quality of Life Scale from Baseline;

Countries

China

Contacts

Public ContactXianzeng Liu

Peking University International Hospital

liuxianzeng2004@sina.com+86 139 1187 9817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026